Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selective estrogen receptor modulators (SERMs) in clinical practice.

L Plouffe1

  • 1Eli Lilly and Co., US Medical Endocrine Division, Indianapolis, Indiana, USA.

Journal of the Society for Gynecologic Investigation
|March 25, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative health effects of margarines fortified with plant sterols and stanols on a rat model for hemorrhagic stroke.

Lipids·2004
Same author

Effect of raloxifene on sexual function in postmenopausal women.

Climacteric : the journal of the International Menopause Society·2003
Same author

The effect of selective estrogen receptor modulators on parameters of the hypothalamic-pituitary-gonadal axis.

Annals of the New York Academy of Sciences·2002
Same author

Raloxifene effect on frequency of surgery for pelvic floor relaxation.

Obstetrics and gynecology·2001
Same author

Raloxifene for breast cancer prevention.

JAMA·2001
Same author

Raloxifene therapy.

Journal of the American Geriatrics Society·2000

Selective estrogen receptor modulators (SERMs) and antiestrogens like clomiphene and tamoxifen offer diverse clinical applications. These agents, including toremifene and raloxifene, are vital in women

Area of Science:

  • Pharmacology and Therapeutics
  • Endocrinology
  • Women's Health

Background:

  • Selective estrogen receptor modulators (SERMs) and antiestrogens are crucial in various medical applications.
  • Four key compounds are currently used in the US: clomiphene (CC), tamoxifen (TAM), toremifene (TOR), and raloxifene (RLX).

Purpose of the Study:

  • To review the clinical data on SERMs and antiestrogens used in the US, excluding breast-related effects.
  • To familiarize readers with the distinct tissue effects and applications of these agents.

Main Methods:

  • Literature review of clinical data on clomiphene, tamoxifen, toremifene, and raloxifene.
  • Analysis of target tissue effects, efficacy, and adverse events.

Main Results:

Related Experiment Videos

  • Clomiphene is primarily used for ovulation induction.
  • Tamoxifen and toremifene are used in breast cancer management and prevention, with potential cardiovascular and skeletal benefits.
  • Raloxifene is indicated for osteoporosis management, with favorable cardiovascular and bone effects.
  • Tamoxifen and toremifene show stimulatory effects on the uterus, while raloxifene is neutral.
  • Hot flashes are common; increased thromboembolic risk exists with continuous use of TAM, TOR, and RLX.

Conclusions:

  • SERMs and antiestrogens possess unique profiles influencing premenopausal and postmenopausal women differently.
  • These agents play significant roles in modern medicine, especially for postmenopausal women's health.
  • Ongoing research continues to expand the understanding and applications of these compounds.